|
ATE456836T1
(de)
*
|
1996-09-04 |
2010-02-15 |
Intertrust Tech Corp |
Zuverlässige infrastrukturhilfssysteme, verfahren und techniken für sicheren elektronischen handel, elektronische transaktionen, handelsablaufsteuerung und automatisierung, verteilte verarbeitung und rechteverwaltung
|
|
PL2041139T3
(pl)
*
|
2006-04-26 |
2012-05-31 |
Hoffmann La Roche |
Związki farmaceutyczne
|
|
AU2007243466B2
(en)
|
2006-04-26 |
2012-01-19 |
F. Hoffmann-La Roche Ag |
Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
|
|
CA2671845C
(en)
*
|
2006-12-07 |
2015-03-24 |
Genentech, Inc. |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
PE20081679A1
(es)
*
|
2006-12-07 |
2008-12-18 |
Hoffmann La Roche |
Compuestos del inhibidor de fosfoinositida 3-cinasa y metodos de uso
|
|
RU2478387C2
(ru)
*
|
2007-02-20 |
2013-04-10 |
Новартис Аг |
ИМИДАЗОХИНОЛИНЫ В КАЧЕСТВЕ ДВОЙНЫХ ИНГИБИТОРОВ ЛИПИДКИНАЗЫ И mTOR
|
|
ATE510841T1
(de)
*
|
2007-06-12 |
2011-06-15 |
Hoffmann La Roche |
Thiazoliopyrimidine und ihre verwendung als hemmer der phosphatidylinositol-3 kinase
|
|
BRPI0816769A2
(pt)
*
|
2007-09-12 |
2016-11-29 |
Hoffmann La Roche |
combinações de compostos inibidores de fosfoinositida 3-cinase e agentes quimioterapêuticos, e métodos de uso
|
|
CN101932587A
(zh)
*
|
2007-09-24 |
2010-12-29 |
吉宁特有限公司 |
噻唑并嘧啶pi3k抑制剂化合物及使用方法
|
|
WO2009055730A1
(en)
|
2007-10-25 |
2009-04-30 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
JP5638955B2
(ja)
*
|
2007-10-26 |
2014-12-10 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｐｉ３キナーゼ阻害剤として有用なプリン誘導体
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
EP2303311B1
(en)
|
2008-05-14 |
2018-08-01 |
Agriculture Victoria Services Pty Ltd |
Angiogenin for use in treating skeletal muscle disorders
|
|
ES2533788T3
(es)
*
|
2008-05-30 |
2015-04-14 |
Genentech, Inc. |
Compuestos inhibidores de PI3K de tipo purina y métodos de uso
|
|
US8163763B2
(en)
*
|
2008-07-31 |
2012-04-24 |
Genentech, Inc. |
Pyrimidine compounds, compositions and methods of use
|
|
TWI378933B
(en)
|
2008-10-14 |
2012-12-11 |
Daiichi Sankyo Co Ltd |
Morpholinopurine derivatives
|
|
CN102186845B
(zh)
*
|
2008-10-17 |
2016-09-07 |
阿卡制药有限公司 |
S1p受体调节剂以及它们的用途
|
|
CA2739901A1
(en)
|
2008-10-17 |
2010-04-22 |
Akaal Pharma Pty Ltd |
S1p receptors modulators
|
|
KR20110098908A
(ko)
*
|
2008-11-11 |
2011-09-02 |
엑스커버리 홀딩 컴퍼니 엘엘씨 |
ＰＩ3Ｋ/ｍＴＯＲ 키나제 억제제
|
|
US8653098B2
(en)
|
2008-11-20 |
2014-02-18 |
Genentech, Inc. |
Pyrazolopyridine PI3K inhibitor compounds and methods of use
|
|
CA2949515C
(en)
|
2009-01-08 |
2018-10-23 |
Axel Becker |
Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
|
|
PT2385832E
(pt)
|
2009-01-08 |
2015-11-02 |
Curis Inc |
Inibidores de fosfoinoritide 3-quinase com uma fração de ligação ao zinco
|
|
JP5709766B2
(ja)
|
2009-03-12 |
2015-04-30 |
ジェネンテック， インコーポレイテッド |
造血器腫瘍の治療のためのホスホイノシチド３キナーゼ阻害剤化合物と化学療法剤の併用
|
|
EP2923734B1
(en)
*
|
2009-03-13 |
2018-01-10 |
Katholieke Universiteit Leuven, K.U. Leuven R&D |
Purine analogues and their use as immunosuppressive agents
|
|
SG172951A1
(en)
|
2009-03-24 |
2011-08-29 |
Sumitomo Chemical Co |
Method for manufacturing a boronic acid ester compound
|
|
CA2756067A1
(en)
*
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics, Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
|
MX2011012520A
(es)
*
|
2009-05-27 |
2011-12-12 |
Hoffmann La Roche |
Compuestos inhibidores de pi3k de pirimidina biciclicos selectivos para p110 delta y metodos de uso de los mismos.
|
|
SG182247A1
(en)
*
|
2009-05-27 |
2012-08-30 |
Hoffmann La Roche |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
EP2445346A4
(en)
*
|
2009-06-24 |
2012-12-05 |
Genentech Inc |
OXOHETEROCYCLIC FUSIONED PYRIMIDINE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
|
|
CA2767008C
(en)
|
2009-07-07 |
2018-01-30 |
Pathway Therapeutics, Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
|
WO2011017520A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Wake Forest University Health Sciences |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
|
UA111579C2
(uk)
|
2009-08-17 |
2016-05-25 |
Інтеллікіне Ллк |
ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ
|
|
NZ597983A
(en)
|
2009-08-20 |
2014-05-30 |
Karus Therapeutics Ltd |
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
|
|
KR20120063515A
(ko)
*
|
2009-09-09 |
2012-06-15 |
아빌라 테라퓨틱스, 인크. |
Ｐｉ３ 키나제 억제제 및 이들의 용도
|
|
EP2475367A1
(en)
*
|
2009-09-10 |
2012-07-18 |
Centre National De La Recherche Scientifique |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
|
US8263633B2
(en)
|
2009-09-28 |
2012-09-11 |
F. Hoffman-La Roche Ag |
Benzoxepin PI3K inhibitor compounds and methods of use
|
|
WO2011049625A1
(en)
|
2009-10-20 |
2011-04-28 |
Mansour Samadpour |
Method for aflatoxin screening of products
|
|
LT2496567T
(lt)
|
2009-11-05 |
2017-11-27 |
Rhizen Pharmaceuticals S.A. |
Nauji benzopirano kinazės moduliatoriai
|
|
WO2011058027A2
(en)
*
|
2009-11-12 |
2011-05-19 |
F. Hoffmann-La Roche Ag |
N-9-substituted purine compounds, compositions and methods of use
|
|
ES2567168T3
(es)
*
|
2009-11-12 |
2016-04-20 |
F. Hoffmann-La Roche Ag |
Compuestos purina y pirazolopirimidina N7-sustituidos, composiciones y métodos de utilización
|
|
US8633183B2
(en)
*
|
2010-01-26 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
5-alkynyl-pyrimidines
|
|
MX2012009059A
(es)
|
2010-02-22 |
2012-09-07 |
Hoffmann La Roche |
Compuestos inhibidores de fosfoinositida 3-cinasa delta (pi3k) pirido [3,2-d]pirimidina y metodos de uso.
|
|
UY33304A
(es)
*
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
MX2013000389A
(es)
|
2010-07-14 |
2013-03-08 |
Hoffmann La Roche |
Compuestos de purina selectivos para fosfatidilinositol 3-cinasa p110 delta, y metodods de uso.
|
|
EA026134B1
(ru)
*
|
2010-12-16 |
2017-03-31 |
Ф. Хоффманн-Ля Рош Аг |
Трициклические ингибиторы pi3k и способы их применения
|
|
EP2667874A4
(en)
*
|
2011-01-27 |
2014-07-30 |
Univ Princeton |
MTOR KINASE HEMMER AS ANTIVIRUS AGENT
|
|
US8653089B2
(en)
|
2011-02-09 |
2014-02-18 |
F. Hoffmann-La Roche Ag |
Heterocyclic compounds and methods of use
|
|
KR20140032383A
(ko)
|
2011-03-21 |
2014-03-14 |
에프. 호프만-라 로슈 아게 |
Pi3k p110 델타에 대하여 선택적인 벤즈옥사제핀 화합물 및 이의 사용 방법
|
|
CN107501241B
(zh)
|
2011-03-28 |
2020-10-13 |
梅制药公司 |
化合物、含有其的药物组合物以及它们在治疗增生性疾病中的用途
|
|
PT3111938T
(pt)
|
2011-04-01 |
2019-07-10 |
Curis Inc |
Inibidores de fosfoinoritide 3-quinase com uma fração de ligação ao zinco
|
|
PT2705029T
(pt)
|
2011-05-04 |
2019-02-01 |
Rhizen Pharmaceuticals S A |
Novos compostos como moduladores de proteína quinases
|
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
|
KR101255939B1
(ko)
*
|
2011-05-31 |
2013-04-23 |
동화약품주식회사 |
4-(1ｈ-인다졸-6-일아미노)-ｎ-아이소프로필-2-(메틸티오)피리미딘-5-카르복스아미드 화합물 또는 이의 약학적으로 허용가능한 염을 포함하는 당뇨병 예방 또는 치료용 조성물
|
|
JP6062442B2
(ja)
*
|
2011-10-13 |
2017-01-18 |
ジェネンテック， インコーポレイテッド |
薬剤誘発性低酸症の治療
|
|
WO2013071264A1
(en)
*
|
2011-11-11 |
2013-05-16 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
|
CN102643272B
(zh)
*
|
2011-12-30 |
2015-03-11 |
沈阳药科大学 |
新的噻吩并[3,2-d]嘧啶类化合物
|
|
GB201204125D0
(en)
|
2012-03-08 |
2012-04-25 |
Karus Therapeutics Ltd |
Compounds
|
|
FR2988722B1
(fr)
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
|
CN103467482B
(zh)
|
2012-04-10 |
2017-05-10 |
上海璎黎药业有限公司 |
稠合嘧啶类化合物，其制备方法，中间体，组合物和应用
|
|
CA2870666A1
(en)
|
2012-04-16 |
2013-10-24 |
Case Western Reserve University |
Compositions and methods of modulating 15-pgdh activity
|
|
US9801863B2
(en)
|
2012-04-16 |
2017-10-31 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
|
|
WO2016144958A1
(en)
|
2015-03-08 |
2016-09-15 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for treating fibrosis
|
|
US9273085B2
(en)
*
|
2012-05-07 |
2016-03-01 |
Kissei Pharmaceutical Co., Ltd. |
Pyrazole derivative and use thereof for medical purposes
|
|
AU2013204740C1
(en)
|
2012-05-10 |
2015-10-01 |
Agriculture Victoria Services Pty Ltd |
Methods of treating cancer using angiogenin or an angiogenin agonist
|
|
CN104350144B
(zh)
|
2012-05-23 |
2017-08-04 |
弗·哈夫曼-拉罗切有限公司 |
获得和使用内胚层和肝细胞的组合物和方法
|
|
CN104379163A
(zh)
|
2012-06-08 |
2015-02-25 |
霍夫曼-拉罗奇有限公司 |
用于治疗癌症的磷酸肌醇3激酶抑制剂化合物和化疗剂的突变选择性及组合
|
|
PT2870157T
(pt)
|
2012-07-04 |
2017-11-27 |
Rhizen Pharmaceuticals S A |
Inibidores seletivos de delta pi3k
|
|
EP2890698B1
(en)
*
|
2012-08-30 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
|
|
WO2014068070A1
(en)
|
2012-10-31 |
2014-05-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preventing antiphospholipid syndrome (aps)
|
|
US9676765B2
(en)
|
2012-11-07 |
2017-06-13 |
Karus Therapeutics Limited |
Histone deacetylase inhibitors and their use in therapy
|
|
CN105283454B
(zh)
|
2013-04-12 |
2019-10-29 |
阿萨纳生物科技有限责任公司 |
作为ras/raf/mek/erk和pi3k/akt/pten/mtor通路双重抑制剂的喹唑啉和氮杂喹唑啉
|
|
SI2994465T1
(sl)
|
2013-05-10 |
2018-10-30 |
Karus Therapeutics Limited |
Novi inhibitorji histon deacetilaze
|
|
DE102013008118A1
(de)
*
|
2013-05-11 |
2014-11-13 |
Merck Patent Gmbh |
Arylchinazoline
|
|
WO2014203129A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
|
JP6441910B2
(ja)
|
2013-09-30 |
2018-12-19 |
シャンハイ インリ ファーマシューティカル カンパニー リミティド |
縮合ピリミジン化合物、中間体、その調製方法、組成物及び使用
|
|
CA2927730A1
(en)
|
2013-10-15 |
2015-05-07 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
CN106831722B
(zh)
|
2013-10-16 |
2019-08-30 |
上海璎黎药业有限公司 |
稠合杂环化合物、其制备方法、药物组合物和用途
|
|
MX2016010056A
(es)
|
2014-02-06 |
2016-11-15 |
Abbvie Inc |
6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso.
|
|
GB201402431D0
(en)
|
2014-02-12 |
2014-03-26 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419228D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419264D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
WO2016154075A1
(en)
*
|
2015-03-20 |
2016-09-29 |
Vertex Pharmaceuticals Incorporated |
Bicyclic heteroaryl compounds useful as inhibitors of the par-2 signaling pathway
|
|
AR104068A1
(es)
|
2015-03-26 |
2017-06-21 |
Hoffmann La Roche |
Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer
|
|
TR201910941T4
(tr)
*
|
2015-03-30 |
2019-08-21 |
Daiichi Sankyo Co Ltd |
6-morfolinil-2-pirazolil-9H-pürin deriveleri ve PI3K inhibitörleri olarak kullanımları.
|
|
EP3283074A4
(en)
*
|
2015-04-14 |
2018-12-05 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
AU2016287189A1
(en)
|
2015-06-29 |
2017-10-12 |
F. Hoffmann-La Roche Ag |
Methods of treatment with taselisib
|
|
GB201514758D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Formulation
|
|
GB201514754D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201514760D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds and method of use
|
|
GB201514751D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
WO2017112777A1
(en)
|
2015-12-22 |
2017-06-29 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
CN107098846B
(zh)
*
|
2016-02-26 |
2020-10-09 |
中国医学科学院药物研究所 |
N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途
|
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
|
SI3464266T1
(sl)
|
2016-06-01 |
2021-12-31 |
Bayer Animal Health Gmbh |
Substituirani indazoli, uporabni pri zdravljenju in preprečevanju alergijskih in/ali vnetnih bolezni pri živalih
|
|
WO2018057588A1
(en)
*
|
2016-09-21 |
2018-03-29 |
Vertex Pharmaceuticals Incorporated |
Furo[3,2-b]pyridine compounds useful as inhibitors of the par-2 signaling pathway
|
|
TW201813963A
(zh)
|
2016-09-23 |
2018-04-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201815787A
(zh)
|
2016-09-23 |
2018-05-01 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
EP3630118A4
(en)
|
2017-05-23 |
2021-03-31 |
MEI Pharma, Inc. |
COMBINATION THERAPY
|
|
KR102736865B1
(ko)
*
|
2017-06-21 |
2024-12-03 |
샤이 테라퓨틱스 엘엘씨 |
암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물
|
|
MX2020001727A
(es)
|
2017-08-14 |
2020-03-20 |
Mei Pharma Inc |
Terapia de combinacion.
|
|
CN109796465B
(zh)
*
|
2017-11-16 |
2020-07-14 |
华中科技大学同济医学院附属协和医院 |
靶向pet显像化合物、包含该化合物的显象剂及其制备方法和用途
|
|
EP3801069A4
(en)
|
2018-06-01 |
2022-03-16 |
Cornell University |
COMBINATION THERAPY FOR A PI3K-ASSOCIATED DISEASE OR DISORDER
|
|
EP3849554B1
(en)
|
2018-09-11 |
2025-01-29 |
Curis, Inc. |
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
JP7598642B2
(ja)
*
|
2018-10-12 |
2024-12-12 |
ボード オブ リージェンツ オブ ザ ユニヴァーシティー オブ ネブラスカ |
ホスホジエステラーゼ阻害剤
|
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
GB201909468D0
(en)
|
2019-07-01 |
2019-08-14 |
Karus Therapeutics Ltd |
Compounds for treating cancer
|
|
US12486274B2
(en)
|
2020-01-13 |
2025-12-02 |
Verge Analytics, Inc. |
Substituted pyrazolo-pyrimidines and uses thereof
|
|
US20240150358A1
(en)
*
|
2020-06-03 |
2024-05-09 |
Kineta, Inc. |
Purines and methods of their use
|
|
CA3198317A1
(en)
*
|
2020-11-10 |
2022-05-19 |
Kevin J. Wilson |
Compounds and uses thereof
|
|
US20240182465A1
(en)
*
|
2021-03-03 |
2024-06-06 |
Genfleet Therapeutics (Shanghai) Inc. |
Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereof
|
|
US20240226126A1
(en)
*
|
2021-06-16 |
2024-07-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions for treatment of psoriasis
|
|
WO2022268025A1
(zh)
*
|
2021-06-22 |
2022-12-29 |
成都苑东生物制药股份有限公司 |
Atr抑制剂及其用途
|
|
CN118019744A
(zh)
*
|
2021-09-30 |
2024-05-10 |
韩美药品株式会社 |
PIKfyve激酶抑制剂
|
|
CN115991716B
(zh)
*
|
2021-10-19 |
2025-10-17 |
中国药科大学 |
嘧啶并环类化合物及其衍生物、制备方法、药物组合物和应用
|
|
US20250084078A1
(en)
*
|
2022-01-04 |
2025-03-13 |
Genfleft Therapeutics (Shanghai) Inc. |
Fused ring-substituted six-membered heterocyclic compound, and preparation method therefor and use thereof
|
|
CN114539293B
(zh)
*
|
2022-02-24 |
2023-09-22 |
广东晨康生物科技有限公司 |
一种噻吩并嘧啶类化合物或其药学上可接受的盐及其制备方法和应用
|
|
AU2023270055A1
(en)
|
2022-05-11 |
2024-11-28 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
CN117164590B
(zh)
*
|
2022-05-25 |
2026-03-17 |
沈阳药科大学 |
稠合嘧啶类衍生物及其应用
|
|
WO2024088991A1
(en)
*
|
2022-10-26 |
2024-05-02 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds capable of activating sting
|